Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

Uložené v:

Podrobná bibliografia
Vydané v:	American journal of respiratory and critical care medicine Ročník 194; číslo 8; s. 1029 - 1031
Hlavní autori:	Lange, Christoph, Duarte, Raquel, Fréchet-Jachym, Mathilde, Guenther, Gunar, Guglielmetti, Lorenzo, Olaru, Ioana D., Oliveira, Olena, Rumetshofer, Rudolf, Veziris, Nicolas, van Leth, Frank
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States American Thoracic Society 15.10.2016
Predmet:	Antitubercular Agents - therapeutic use Clinical Protocols - standards Drug Administration Schedule Eligibility Determination - standards Europe Humans Practice Guidelines as Topic Treatment Outcome Tuberculosis, Multidrug-Resistant - drug therapy World Health Organization
ISSN:	1073-449X, 1535-4970, 1535-4970
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Popis
Bibliografia:	SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Article-2 ObjectType-Correspondence-1 content type line 23
ISSN:	1073-449X 1535-4970 1535-4970
DOI:	10.1164/rccm.201606-1097LE